Literature DB >> 29268693

Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.

Marios Hadjivassiliou1.   

Abstract

The identification of an increasing number of immune mediated ataxias suggests that the cerebellum is often a target organ for autoimmune insults. The diagnosis of immune mediated ataxias is challenging as there is significant clinical overlap between immune mediated and other forms of ataxia. Furthermore the classification of immune mediated ataxias requires further clarification particularly for those ataxias where no specific antigenic trigger and associated antibodies have been identified. Recognition of immune mediated ataxias remains imperative as therapeutic interventions can be effective, although given the relative rarity of this entity, large-scale treatment trials may not be feasible. This review will discuss advances in therapies for immune mediated ataxias based on what is currently available in the literature. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cerebellar ataxia; cerebellum; gluten ataxia; paraneoplastic cerebellar degeneration; primary autoimmune cerebellar ataxia; vertebrate nervous system.

Mesh:

Substances:

Year:  2019        PMID: 29268693     DOI: 10.2174/1871527317666171221110548

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  1 in total

1.  The Significance of Low Titre Antigliadin Antibodies in the Diagnosis of Gluten Ataxia.

Authors:  Marios Hadjivassiliou; Richard A Grünewald; David S Sanders; Panagiotis Zis; Iain Croal; Priya D Shanmugarajah; Ptolemaios G Sarrigiannis; Nick Trott; Graeme Wild; Nigel Hoggard
Journal:  Nutrients       Date:  2018-10-05       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.